VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients

被引:7
|
作者
Englert, F. [1 ]
Bahlke, F. [1 ]
Erhard, N. [1 ]
Krafft, H. [1 ]
Popa, M. -a. [1 ]
Risse, E. [1 ]
Lennerz, C. [1 ]
Lengauer, S. [1 ]
Telishevska, M. [1 ]
Reents, T. [1 ]
Kottmaier, M. [1 ]
Kolb, C. [1 ]
Hessling, G. [1 ]
Deisenhofer, I. [1 ]
Bourier, F. [1 ]
机构
[1] Tech Univ Munich TUM, German Heart Ctr Munich, Dept Electrophysiol, Lazarettstr 36, D-80636 Munich, Germany
关键词
VT ablation; inHEART; Cardiomyopathy; Wall thinning; Late enhancement; VENTRICULAR-TACHYCARDIA; SCAR;
D O I
10.1007/s00392-023-02321-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The eradication of ventricular tachycardia (VT) isthmus sites constitutes the minimal procedural endpoint for VT ablation procedures. Contemporary high-resolution computed tomography (CT) imaging, in combination with computer-assisted analysis and segmentation of CT data, facilitates targeted elimination of VT isthmi. In this context, inHEART offers digitally rendered three-dimensional (3D) cardiac models which allow preoperative planning for VT ablations in ischemic and non-ischemic cardiomyopathies. To date, almost no data have been collected to compare the outcomes of VT ablations utilizing inHEART with those of traditional ablation approaches.Methods The presented data are derived from a retrospective analysis of n = 108 patients, with one cohort undergoing VT ablation aided by late-enhancement CT and subsequent analysis and segmentation by inHEART, while the other cohort received ablation through conventional methods like substrate mapping and activation mapping. The ablations were executed utilizing a 3D mapping system (Carto3), with the mapping generated via the CARTO (R) PENTARAY (TM) NAV catheter and subsequently merged with the inHEART model, if available.Results Results showed more successful outcome of ablations for the inHEART group with lower VT recurrence (27% vs. 42%, p < 0.06). Subsequent analyses revealed that patients with ischemic cardiomyopathies appeared to derive a significant benefit from inHEART-assisted VT ablation procedures, with a higher rate of successful ablation (p = 0.05).Conclusion Our findings indicate that inHEART-guided ablation is associated with reduced VT recurrence compared to conventional procedures. This suggests that employing advanced imaging and computational modeling in VT ablation may be valuable for VT recurrences.
引用
收藏
页码:1478 / 1484
页数:7
相关论文
共 50 条
  • [21] Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity-score matched analysis
    Gomes, Daniel A.
    Paiva, Mariana Sousa
    Matos, Daniel
    Bello, Ana Rita
    Rodrigues, Gustavo
    Carmo, Joao
    Ferreira, Jorge
    Costa, Francisco Moscoso
    Santos, Pedro Galvao
    Carmo, Pedro
    Cavaco, Diogo
    Morgado, Francisco Bello
    Adragao, Pedro
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2024, 43 (06) : 341 - 349
  • [22] Superior quality of life in patients with non-ischemic dilated cardiomyopathy and implantable cardioverter-defibrillators: Results from the defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) study
    Passman, R
    Anderson, KP
    Subacius, H
    Schaechter, A
    Howard, A
    Calkins, H
    Kadish, A
    CIRCULATION, 2004, 110 (17) : 625 - 625
  • [23] Comparison Of LVAD Outcomes In Patients With Non-ischemic Cardiomyopathy And Ischemic Cardiomyopathy: Insight From National Readmission Database
    Abumoawad, Abdelrhman
    Shatla, Islam
    Wahood, Waseem
    Noman, Anas
    Peri-Okonny, Poghni
    Magalski, Anthony
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S51 - S52
  • [24] Comparing Outcomes Of Non-Ischemic Cardiomyopathy And Ischemic Cardiomyopathy In Patients Admitted With Sepsis: A Nationwide Analysis
    Thakkar, Aditya
    Gupta, Soumya
    Namburu, Lalith
    Kumar, Dilpat
    Vedantam, Venkata
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01) : 208 - 209
  • [25] FLECAINIDE AND PROPAFENONE SAFETY IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY
    Sherman, Andrew
    Tawney, Adam
    Mehta, Nishaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 128 - 128
  • [26] Substrate Characterization and Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients with Non-Ischemic Dilated Cardiomyopathy and Isolated Apical Scar
    Liao, Yi Wen Becky
    Baranowski, Bryan
    Bhargava, Mandeep
    Callahan, Thomas
    Chung, Mina
    Courson, Jeff
    Dresing, Thomas
    Higuchi, Koji
    Hight, Nolan
    Hussein, Ayman
    Kanj, Mohamed
    Kochar, Arshneel
    Koeth, Robert
    Lee, Justin
    Martin, David
    Mayuga, Kenneth
    Nakhla, Shady
    Rickard, John
    Saliba, Walid
    Sroubek, Jakub
    Taigen, Tyler
    Varma, Niraj
    Wazni, Oussama
    CIRCULATION, 2024, 150
  • [27] Clinical determinants of mortality in patients with angiographically proven ischemic and non-ischemic cardiomyopathy
    Bart, BA
    Shaw, LK
    McCants, CB
    Fortin, DF
    Lee, KL
    OConnor, CM
    CIRCULATION, 1996, 94 (08) : 1121 - 1121
  • [28] Computed tomography: The optimal imaging method for differentiation of ischemic vs non-ischemic cardiomyopathy
    Danad, Ibrahim
    Min, James K.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2015, 22 (05) : 961 - 967
  • [29] Computed tomography: The optimal imaging method for differentiation of ischemic vs non-ischemic cardiomyopathy
    Ibrahim Danad
    James K. Min
    Journal of Nuclear Cardiology, 2015, 22 : 961 - 967
  • [30] Comparison of Resynchronization Therapy in Heart Failure Patients With Ischemic And Non-Ischemic Cardiomyopathy
    Baimbetov, Adil
    Yakupova, Ilinara
    Bizhanov, Kenzhebek
    Bozshagulov, Tungushbek
    Tursunkhanov, Zhalolkhan
    Bigeldiyev, Nurbolat
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 : S67 - S68